
Search
Filter Results
Displaying 351–360 of 624 for “retinal diseases”
-
Sep 7, 2023
First Patient Dosed in LCA5 Gene Therapy Clinical Trial Launched by Opus Genetics
Opus was established by the RD Fund, the Foundation’s venture philanthropy arm
-
Nov 18, 2022
Editas Reports Results for 14 Participants in its Phase 1/2 CRISPR/Cas9 Clinical Trial for LCA10
The company is seeking a partner to move the LCA10 program forward
-
Oct 12, 2022
Eye on the Cure Podcast | Episode 33: Jacque Duncan, MD
October 7, 2022. Ben Shaberman talks with Jacque Duncan, MD.
-
Sep 26, 2022
SeeShore Fest Fundraiser Success
Heather Napolitano started her DIY fundraiser, SeeShore Fest, seven years ago. The event has now raised over $109,000 to fund research finding treatments and cures for blinding diseases.
-
Aug 15, 2022
Decades of Dedication Fighting for His Family and Himself
Dan Day is one of over ten people in his family, spanning six generations, affected with retinitis pigmentosa (RP). So to “get off the sidelines and join the fight” for himself and his family, Dan has dedicated over 25 years of service to the Foundation Fighting Blindness.
-
May 9, 2022
Gene Knock-Out, Replacement Therapy for RP-RHO Performed Well in Lab Study
Editas is planning IND-enabling studies of the two-part treatment in preparation for a clinical trial
-
Apr 26, 2022
“Great Vision Does Not Require Great Sight”
Kenyetta has worked to help others through the nonprofit sector for over 25 years, despite being diagnosed with Stargardt disease at the age of 31. Kenyetta is now the chief operating officer of REACH Riverside Development Corporation and has been recognized for her career achievements by many.
-
Jan 28, 2021
The company plans to enroll additional patients as young as four years old
-
Dec 21, 2020
At seven years old, Hannah had never seen a lightning bug in the summer or a star in the sky. But after her treatment with LUXTURNA, Hannah can now play outside at night with her brothers and has a new bright future in store.
-
Making a stock donation is a powerful way to support the mission of the Foundation Fighting Blindness to drive the research for treatments and cures for blinding diseases affecting 1 in 53 individuals around the world.